CN Patent

CN107628975B — 赖氨酸衍生物类组蛋白去乙酰化酶抑制剂及其合成和应用

Assigned to Guizhou Medical University · Expires 2019-10-29 · 7y expired

What this patent protects

本发明公开了一种赖氨酸衍生物类组蛋白去乙酰化酶抑制剂，所述的抑制剂选择性高，可用于对Sirtuin选择性强、高效低毒的Sirtuin机理型抑制剂类抗肿瘤药物，原料易得，成本低。

USPTO Abstract

本发明公开了一种赖氨酸衍生物类组蛋白去乙酰化酶抑制剂，所述的抑制剂选择性高，可用于对Sirtuin选择性强、高效低毒的Sirtuin机理型抑制剂类抗肿瘤药物，原料易得，成本低。

Drugs covered by this patent

Patent Metadata

Patent number
CN107628975B
Jurisdiction
CN
Classification
—
Expires
2019-10-29
Drug substance claim
No
Drug product claim
No
Assignee
Guizhou Medical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.